From cyclophosphamide hematotoxicity to modeling cancer.
Luebeck
E G
EG
Fred Hutchinson Cancer Research Center, Division of Public Health Sciences, Seattle, Washington 98109-1024, USA. gluebeck@fhcrc.org
D000818:Animals; D001554:Benzene / Q000493:pharmacokinetics / Q000633:toxicity; D002273:Carcinogens / Q000493:pharmacokinetics / Q000633:toxicity*; D003520:Cyclophosphamide / Q000493:pharmacokinetics / Q000633:toxicity*; D004305:Dose-Response Relationship, Drug; D006402:Hematologic Diseases / Q000139:chemically induced; D006412:Hematopoietic Stem Cells / Q000187:drug effects*; D006801:Humans; D007938:Leukemia / Q000139:chemically induced*; D008954:Models, Biological; D011237:Predictive Value of Tests; D016016:Proportional Hazards Models; D018570:Risk Assessment
D002273:Carcinogens; D003520:Cyclophosphamide; D001554:Benzene